Superior Hypogastric Plexus Block Versus Pulsed Radiofrequency for Chronic Pelvic Cancer Pain
Unknown statusNot applicableNCT03228316
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Cancer-related pain represents a major challenge for both clinicians and patients. This pain can be associated directly with the cancer or with certain treatments administered to the patient. 52.1% of cancer patients suffer from pain and that 62.6% are not satisfied with the current pain treatment. Pain prevalence is high in developing countries due to late diagnosis and major impediments to opioid access
Study details
- Official title
- Superior Hypogastric Plexus Block and Pulsed Radiofrequency on Dorsal Root Ganglia of Sacral Nerves for Chronic Pelvic Cancer Pain
- Conditions
- Chronic Pelvic Cancer Pain
- Interventions
- Procedure: superior hypogastric plexus block
- Radiation: pulsed radiofrequency
- Sponsor
- Assiut University
- Start date
- 2019-10-20
- Primary completion
- 2020-06-20
- Sex
- All
- Age range
- from 18 Years to 70 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * sympathetically maintained pelvic, perineal pain * pain is no longer controlled with oral morphine sustained release tablets 30 mg * excessive sedation or other side effects from oral morphine sustained release tablets 30 mg or amitryptyline tablets 25 mg * age between 18-70 years Exclusion Criteria: * patient refusal * patients with coagulopathies * allergy to constant dyes or phenol * patients receiving radiation or chemotherapy within 4 weeks of neurolytic block * patients with major or moderate cardiac/respiratory incapacitating diseases * liver and renal failure * patients younger than 18 years and older than 70 years
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03228316